• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.70% Nasdaq Down 0.63%

    Navidea Biopharmaceuticals, Inc (NAVB)

    -NYSE MKT
    1.28 Down 0.01(0.70%) 2:50PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:1.29
    Open:1.28
    Bid:1.29 x 1300
    Ask:1.30 x 2900
    1y Target Est:5.00
    Beta:1.04
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:1.28 - 1.31
    52wk Range:0.97 - 2.02
    Volume:101,340
    Avg Vol (3m):452,131
    Market Cap:192.07M
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NAVB

    Comparison

    Symbol% ChgMkt Cap
    NAVBDown 0.70%192.07M
    LLYUp 1.87%82.43B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):25.35
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.16
    Quarterly EPS Est (Jun-15) :-0.04
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Navidea Biopharmaceuticals, Inc., a precision medicine company, focuses on the development and commercialization of precision diagnostics, therapeutics, and radiopharmaceutical agents. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback